Vitamin B2 Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Sales Channel (Direct, Indirect), By End Use (Animal feed, Pharmaceuticals & Supplements, Food & Beverage Fortification, Colorant, Others), By Region and Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 513.03 Million
CAGR (2026-2031)	4.47%
Fastest Growing Segment	Direct
Largest Market	North America
Market Size (2031)	USD 666.95 Million

Market Overview

The Global Vitamin B2 Market is projected to grow from USD 513.03 Million in 2025 to USD 666.95 Million by 2031 at a 4.47% CAGR. Vitamin B2, also known as riboflavin, is a water soluble micronutrient essential for energy metabolism, cellular function, and the synthesis of other vitamins. The global market is primarily supported by the expanding animal nutrition sector where the substance serves as a critical feed additive for livestock health and growth. Additionally, rising consumer awareness regarding preventative healthcare has spurred demand for dietary supplements and fortified food products. These fundamental drivers are distinct from emerging market trends such as the increasing preference for biological fermentation production methods and clean label ingredients.

Despite the positive growth trajectory, the market faces significant challenges related to the high concentration of manufacturing capacity in specific regions which creates supply chain vulnerabilities. This geographic dependency often leads to price volatility during regulatory changes or logistical disruptions. Highlighting this manufacturing dominance, according to the China Chamber of Commerce for Import and Export of Medicines and Health Products, in March 2024, the export value of Vitamin B2 from China reached approximately USD 11 million. Such figures underscore the pivotal role of major production hubs in sustaining the global supply chain.

Key Market Drivers

Escalating demand for fortified animal feed additives serves as the primary engine for market expansion, as riboflavin is a fundamental micronutrient required for livestock metabolism and growth efficiency. Modern industrial farming practices, particularly in the poultry and swine sectors, necessitate precise vitamin B2 supplementation to prevent deficiency disorders and maximize feed conversion ratios. This intense reliance on fortified additives is directly correlated with the steady enlargement of the global feed industry to meet protein consumption needs. According to Alltech, April 2025, in the '2025 Agri-Food Outlook', global feed production volumes expanded to reach 1.396 billion metric tons in 2024, representing a 1.2% increase that underpins the consistent industrial requirement for riboflavin.

Simultaneously, the expansion of the functional food and beverage sector acts as a robust secondary driver, fueled by heightened consumer awareness regarding energy metabolism and preventive healthcare. As individuals increasingly prioritize wellness, manufacturers are expanding product lines to include Vitamin B2 in sports nutrition and fortified snacks due to its role in cellular energy production. According to WholeFoods Magazine, February 2025, in the article 'Highlights from CRN's 2024 Consumer Survey', consumer usage of sports nutrition products—a key category for B-complex fortifications—rose to 45% in 2024. This sustained end-user demand helps stabilize the market against broader supply chain fluctuations. Highlighting the financial magnitude of the sector consuming these ingredients, according to dsm-firmenich, February 2025, in the 'Integrated Annual Report 2024', the company's Animal Nutrition & Health division alone generated annual revenues exceeding €3.3 billion.

Download Free Sample Report

Key Market Challenges

The Global Vitamin B2 Market is significantly hampered by the high concentration of manufacturing capacity in a single geographic region, which creates acute supply chain vulnerabilities. This centralization creates a bottleneck where global availability is inextricably linked to the operational stability of a few major producers. Consequently, any local regulatory changes, energy shortages, or logistical disruptions in the primary manufacturing hub can precipitate immediate global shortages and sharp price volatility. This uncertainty complicates long-term procurement strategies for international buyers in the animal nutrition and pharmaceutical sectors, who often struggle to secure consistent supply contracts at stable rates, thereby constraining broader market stability and expansion.

The extent of this geographic reliance is evident in recent trade performance figures that highlight the sheer scale of the dominant production hub. According to the China Chamber of Commerce for Import and Export of Medicines and Health Products, in the first quarter of 2025, the export value of Western medicine raw materials, a sector significantly driven by vitamin production, reached USD 11.1 billion. Such heavy dependence on a single source region forces global stakeholders to absorb higher risk premiums and manage fluctuating inventory levels, directly impeding steady market growth.

Key Market Trends

Fortification of Plant-Based Dairy Alternatives involves the systematic addition of riboflavin to non-dairy beverages to replicate the nutritional profile of bovine milk. As consumers increasingly substitute traditional dairy with oat, almond, and soy varieties, manufacturers are compelled to address the natural deficiency of Vitamin B2 in plant sources to maintain product competitiveness and nutritional parity. This application demand is directly scaling with the sector's commercial expansion, as brands prioritize "complete nutrition" claims to retain health-conscious buyers. According to the Good Food Institute, April 2025, in the '2024 State of the Industry' report, global retail sales of plant-based meat and dairy alternatives rose to reach USD 28.6 billion in 2024, creating a substantial and growing baseline requirement for riboflavin fortification in these formulated products.

Adoption of Microencapsulation Technologies is reshaping the market by overcoming the inherent stability and taste challenges of incorporating riboflavin into functional foods and advanced supplements. This processing innovation protects the vitamin from oxidation and light degradation while masking its naturally bitter flavor, enabling its use in a wider array of delivery formats beyond traditional tablets. Furthermore, advanced encapsulation techniques are now being deployed to control release profiles for specific health outcomes, such as gut microbiome support. Illustrating this technological advancement, according to dsm-firmenich, February 2025, in the 'Integrated Annual Report 2024', the company launched a new biotic vitamin solution utilizing proprietary encapsulation that delivers 90% of the riboflavin directly to the colon, significantly enhancing bioavailability compared to free forms.

Segmental Insights

The Direct sales segment is currently the fastest-growing category within the Global Vitamin B2 Market. This expansion is primarily driven by the increasing preference among large-scale animal feed and pharmaceutical manufacturers to procure riboflavin directly from producers, bypassing third-party distributors. By eliminating intermediaries, these buyers achieve significant cost efficiencies and secure a more consistent supply chain. Furthermore, stricter guidelines from regulatory bodies such as the U.S. Food and Drug Administration (FDA) and the European Food Safety Authority (EFSA) regarding ingredient traceability encourage companies to establish direct relationships with manufacturers to ensure rigorous quality assurance and compliance.

Regional Insights

North America holds a dominant position in the Global Vitamin B2 Market due to substantial demand from the pharmaceutical and food and beverage sectors. The United States Food and Drug Administration plays a critical role by enforcing regulations that mandate the fortification of various grain and cereal products with riboflavin, directly sustaining industrial consumption. Furthermore, the region benefits from widespread consumer adoption of dietary supplements aimed at preventative healthcare. This combination of regulatory support for food enrichment and a strong preference for nutritional products secures North America as the leading revenue generator in the global market.

Recent Developments

• In December 2025, Adisseo released the 2026 edition of its Microvit Nutrition Guide, a key technical resource for the global feed industry. This updated publication provided revised recommendation levels for vitamin supplementation, including Vitamin B2 (riboflavin), across 18 different animal species and 35 developmental stages. The company developed these guidelines based on an extensive review of scientific literature from the past three decades, combined with internal research and industry consultation. The guide addressed evolving challenges such as faster animal growth rates and heat stress, aiming to optimize animal performance and meat quality through precise vitamin nutrition.
• In February 2025, Chifeng Pharmaceutical Co., Ltd. received a positive safety assessment from the European Food Safety Authority (EFSA) for its Vitamin B2 feed additives. The EFSA FEEDAP Panel published an opinion confirming that the company's riboflavin (98%) and riboflavin (80%), produced by fermentation with a genetically modified strain of Bacillus subtilis (CGMCC 7.449), raise no safety concerns for target species, consumers, or the environment. The scientific review verified the absence of viable cells and DNA from the production strain in the final product, supporting the use of this fermentation-derived vitamin B2 in global animal nutrition supply chains.
• In November 2024, Hubei Guangji Pharmaceutical Co., Ltd. achieved a regulatory milestone for its riboflavin production with a favorable scientific opinion from the European Food Safety Authority (EFSA). The EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) concluded that the company’s Vitamin B2/riboflavin feed additive, produced using the Eremothecium ashbyi strain CCTCCM 2019833, is safe for all animal species, consumers, and the environment. This assessment validated the safety of the manufacturing process and the strain used, facilitating the company's continued access to the European market for its animal nutrition products.
• In May 2024, dsm-firmenich launched a new riboflavin-based ingredient, Humiome B2, at the Vitafoods Europe trade show in Geneva. The company marketed this product as the world's first "biotic" vitamin, designed with a proprietary Microbiome Targeted Technology to deliver approximately 90% of the riboflavin directly to the colon. Unlike standard Vitamin B2, which is primarily absorbed in the small intestine, this new formulation was developed to nourish the gut microbiome and support immunity, gut barrier integrity, and metabolic health. The launch represented a strategic expansion of the company's "Health from the Gut" portfolio.

Key Market Players

• Hubei Guangji Pharmaceutical Co., Ltd
• dsm-firmenich
• BASF SE
• Haijianuo Pharmaceutical Co., Ltd.
• Zhejiang Shengda Bio-Pharm Co Ltd.
• Shandong Hongda Biological Technology Co., Ltd.
• Xinfa Pharmaceutical Co. Ltd
• N.B Group Co. Ltd

By Sales Channel	By End Use	By Region
Direct Indirect	Animal feed Pharmaceuticals & Supplements Food & Beverage Fortification Colorant Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Vitamin B2 Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Vitamin B2 Market, By Sales Channel:

• Direct
• Indirect

• Vitamin B2 Market, By End Use:

• Animal feed
• Pharmaceuticals & Supplements
• Food & Beverage Fortification
• Colorant
• Others

• Vitamin B2 Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE